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A B S T R A C T
Objective: Investigate the association of rs17465637 gene MIAF3 (1q41), rs1376251 gene TAS2R50
(12p13), rs4804611 gene ZNF627 (19p13), rs619203 gene ROS1 (6q22), rs1333049 (9p21), rs10757278
(9p21), rs2549513 (16q23), rs499818 (6p24) associated with myocardial infarction available from the
international genome-wide studies with sudden cardiac death (SCD) in a case–control study.
Methods: A sample of SCD cases (n = 285) was formed using the WHO criteria; the control sample
(n = 421) was selected according to sex and age. DNA was isolated by phenol–chloroform extraction from
the myocardial tissue of SCD cases and blood of control cases. The groups were genotyped for the
selected SNPs by real-time PCR using TaqMan probes (Applied Biosystems, United States).
Results: No statistically signiﬁcant differences in the genotype and allelic frequencies of studied single
nucleotide polymorphisms between sudden cardiac death cases and control were detectable in general
group. By separating the groups of sex and age differences in the genotype frequencies of rs1333049,
rs10757278 and rs499818 are statistical signiﬁcance. Genotypes CC of rs1333049 and GG of rs10757278
are associated with an increased sudden cardiac death risk in men (p = 0.019, OR = 1.7, 95% CI 1.1–2.8;
p = 0.011, OR = 1.8, 95% CI 1.2–2.8, respectively). Genotype AG of rs499818 is associated with an
increased sudden cardiac death risk in the women over 50 years old (p = 0.009, OR = 2.4, 95% CI 1.3–4.6).
Conclusion: Polymorphisms rs1333049 and rs10757278 are associated with SCD in men and rs499818 in
the women aged over 50 years.
 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Cardiovascular diseases are still leading causes of population
mortality in many countries of the world. According to the WHO
data as of 2010, 56.8% of all fatal cases in the Russian Federation are
caused by cardiovascular diseases, with ischemic heart disease
(IHD) accounting for 29.5%.1 Sudden cardiac death (SCD) is one of
the IHD forms in the WHO classiﬁcation (International Classiﬁca-
tion of Diseases 10th revision); it can develop on the background of
a current cardiovascular disease or be a solitary disease
manifestation. SCD is a multifactorial state, contributors to which
are both genetic and environmental factors. Development of the* Corresponding author at: Laboratory of Molecular Genetic Studies of Internal
Diseases, Federal State Budgetary of Scientiﬁc Institution ‘‘Institution of Internal
and Preventive Medicine’’, ul. B. Bogatkova 175/1, Novosibirsk 630089, Russia.
E-mail addresses: ivanova_a_a@mail.ru (A.A. Ivanova), medik11@mail.ru
(V.N. Maksimov), orlovpavel86@gmail.com (P.S. Orlov), dinara2084@mail.ru
(D.E. Ivanoshchuk), mvoevoda@ya.ru (M.I. Voevoda).
Please cite this article in press as: Ivanova AA, et al. Association of th
death, Indian Heart J. (2016), http://dx.doi.org/10.1016/j.ihj.2016.07.
http://dx.doi.org/10.1016/j.ihj.2016.07.016
0019-4832/ 2016 Published by Elsevier B.V. on behalf of Cardiological Society of
creativecommons.org/licenses/by-nc-nd/4.0/).predictive component in modern medicine, on the one hand, and
the absence of reliable and affordable tools for diagnosing
predisposition for SCD development, on the other, encourage
the research into genetic factors underlying development of this
IHD from. Numerous current genome-wide association and case–
control studies deal with the genetic predisposition for IHD and
myocardial infarction (MI).2–5 However, the studies on the
associations of gene polymorphisms and mutations with SCD
are still rather few and almost absent in the Russia. Recent
genome-wide studies have detected the association of some single
nucleotide polymorphisms (SNPs) with an increased risk of IHD
and, in particular, myocardial infarction.2,6 According to ICD-10,
SCD does not include the death of myocardial infarction; however,
the clinical picture and the mechanism of fatal outcome
development in SCD and myocardial infarction are rather similar.
We assumed that the SNPs associated with the development of
myocardial infarction might also contribute to SCD development.
So the aim of this study is investigate the association of
rs17465637 gene MIAF3, rs1376251 gene TAS2R50, rs4804611e genetic markers for myocardial infarction with sudden cardiac
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rs2549513, rs499818 associated with myocardial infarction
available from the international genome-wide studies with sudden
cardiac death.
The associations of rs619203 gene ROS1, rs1376251 gene
TAS2R50, and rs4804611 gene ZNF627 with MI were ﬁrst detected
in a multistage study involving 11,053 SNPs.7 Rs499818 and
rs2549513 were detected in the genome-wide Framingham Heart
Study as most likely associated with widespread IHD outcomes,
namely, MI, stroke, and fatal IHD outcome. The fatal IHD outcome
was regarded as the death caused by IHD after exclusion of the
remaining causes. Also, in Framingham Heart Study a 13-Kb locus
of chromosome 9 (9p21) displayed the association of MI, stroke,
and fatal IHD outcome; this locus contains several SNPs, including
rs1333049 and rs10757278.6 In the list of SNPs associated with MI,
IHD was included rs17465637, which is based on the results of
joint research analysis with a probability greater than 80% is
associated with coronary artery disease (OR 1.20).8
2. Methods
The design of study is a case–control. The bank of SCD cases for
1999–2012 (n = 285; mean age, 53.2  8.8 years; men, 69.9%; and
women, 30.1%) was formed. The group included people who died
suddenly in Oktyabr’skii district, Novosibirsk, Russia subject to
forensic examination which was conducted according to standard
protocol by a qualiﬁed medical examiner. Standard protocol includes
examination of the corpse, an autopsy and examination of body
cavities, extracting organocomplexes, the study of organs and tissues,
taking material for histological studies. Taking into account a limited
volume of information on the time of fatal event development, the
formed group contains the fatal cases that developed during 1 h or no
more than 24 h in the absence of witnesses and estimated as a death
of cardiac genesis according to autopsy. The main postmortem
diagnosis is acute coronary insufﬁciency and acute circulatory failure.
The presence of morphological changes in the cardiac tissue typical
for myocardial infarction or cardiomyopathies was the exclusion
criteria. The persons in a state of alcoholic and drug intoxication
identiﬁed during the chemical research were excluded from the
group. According to the protocols of a forensic study 56.4% of SCD
persons have signs of atherosclerosis (75.7% of them – signs of aortic
atherosclerosis, 95.7% – signs of coronary atherosclerosis).
The control group was selected statistical comparable in sex
and age of the group SCD at a ratio of 3 control individuals to 2 SCD
case from the DNA bank of Health, Alcohol and Psychosocial factors
In Eastern Europe (HAPIEE) international project that covered the
same district of Novosibirsk (n = 421; mean age, 59.3  6.5 years;
men, 64.1%; and women, 35.9%). HAPIEE is a prospective cohort study
to examine the effects of traditional and nontraditional risk factors,
social and psychosocial factors in the development of cardiovascular
and other noncommunicable diseases in Eastern Europe. Protocol of
study included a questionnaire of social and economic life’s
conditions, history of chronic disease, the state of physical activity
and health. The examination included the measurement of growth,
body weight, blood pressure, heart rate, circumferences of chest,
waist and hips. Also respiratory and cognitive functions were
investigated. The control group included individuals without coro-
nary artery disease and myocardial infarction in anamnesis. The
individuals from control group did not have criteria of angina pectoris
in the questionnaire of G.A. Rose. The ECG also showed no signs of
myocardial ischemia, cicatricial changes of the myocardium.
DNA was isolated by phenol–chloroform extraction from the
myocardial tissue of SCD cases and blood of control cases.9
The groups were genotyped for the selected SNPs rs17465637,
rs2549513, rs1376251, rs499818, rs4804611, rs619203, rs1333049,Please cite this article in press as: Ivanova AA, et al. Association of th
death, Indian Heart J. (2016), http://dx.doi.org/10.1016/j.ihj.2016.07.rs10757278 by real-time PCR in an ABI 7900HT device using
TaqMan probes (Applied Biosystems, United States).
The data were statistically processed with the help of SPSS
16.0 software package; the genotype and allelic frequencies of the
studied SNPs were determined in the SCD and control groups. The
cohorts were compared according to the genotype and allelic
frequencies with the help of contingency tables using x2 test
according to Pearson. In the case of fourfold tables, two-sided
Fisher’s exact test with Yates’ correction for continuity was used. A
relative SCD risk for particular allele or genotype was calculated as
the ratio of changes using two-sided Fisher’s exact test and
Pearson’s x2 test. The examination of linkage disequilibrium was
performed using pair-wise r2 and D0 statistics in CubeX.
The study was approved by ethics committee of Federal State
Budgetary of Scientiﬁc Institution ‘‘Institution of Internal and
Preventive Medicine’’.
3. Results
Eight SNPs regarded as the markers associated with MI and
IHD according to the data of international genome-wide studies
have been tested for their potential association with SCD, namely,
SNPs rs17465637, rs2549513, rs1376251, rs499818, rs4804611,
rs619203, rs1333049, and rs10757278 (Table 1).
The frequencies of genotypes of rs17465637, rs2549513,
rs1376251, rs499818, rs619203, in the control group are in
Hardy–Weinberg equilibrium. The genotype frequencies of
rs1333049, rs10757278, rs4804611 in the control group deviated
from Hardy–Weinberg equilibrium (x2 = 5.22, p = 0.022; x2 = 4.66,
p = 0.031; x2 = 3.91, p = 0.048, respectively). Genotyping errors
were excluded using PCR and subsequent restriction fragment
length polymorphism (RFLP) analysis by original techniques. The
results of real-time PCR are identical to the results of PCR-RFLP. In
the age group under 50 years genotype frequencies of rs1333049,
rs10757278 are in Hardy–Weinberg equilibrium, and in the group
older than 50 years there are deviations from it. This may indicate a
loss to some genotypes in a population with age, with a
corresponding increase in the share of other genotypes in it.
No statistically signiﬁcant differences were detectable when
comparing the SCD and control cohorts according to the genotype
and allelic frequencies of rs17465637, rs2549513, rs1376251,
rs4804611, rs619203.
Found statistically signiﬁcant differences in allele frequencies
of rs1333049 in the SCD group and control group (p = 0.024). In the
group of SCD homozygous genotype CC of rs1333049 and
homozygous genotype GG of rs10757278 increase compared with
the control group, but the difference did not statistical signiﬁcance
(p = 0.052 and p = 0.059, respectively). By separating the groups of
sex these differences are statistical signiﬁcance. The odd ratio
found in the group of men who died SCD carrier GG genotype
rs10757278 (26.4%) is 1.8 times higher than in the control group of
men (17.2%) (95% CI 1.2–2.8, p = 0.011), and genotype CC
rs1333049 (26.2%) 1.7 times higher in group of men who died
suddenly than in the control group of men (16.9%) (95% CI 1.1–2.8,
p = 0.019).
The group of women over 50 years old displayed statistically
signiﬁcant differences in the genotype frequencies of SNP
rs499818. The share of carriers of AG genotype is 2.4-fold higher
in SCD group of women over 50 years old (55.6%) as compared with
the control group of women over 50 years old (34.1%) at 95% CI of
1.3–4.6 and p = 0.009.
In addition we examined the correlation among rs1333049 and
rs10757278 (based on the literature) using pair-wise r2 and D0
statistics for linkage disequilibrium. In control group D0 was
0.978 and r2 was 0.9511.e genetic markers for myocardial infarction with sudden cardiac
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Genotype frequencies in groups.
SNP Genotype SCD Control group pa
N (total number) % N (total number) %
rs17465637 AA 13 4.6 30 7.4 0.338
AC 121 43.2 167 41.0
CC 146 51.2 210 51.6
rs2549513 AA 195 69.4 288 69.2 0.436
AC 82 29.2 116 27.9
CC 4 1.4 12 2.9
rs1376251 CC 122 46.2 214 51.6 0.281
CT 110 41.7 163 39.3
TT 32 12.1 38 9.2
rs499818 AA 18 6.3 32 7.6 0.265
AG 117 40.9 147 35.0
GG 151 52.8 241 57.4
rs4804611 AA 167 58.6 226 54.1 0.370
AG 103 36.1 173 41.4
GG 15 5.3 19 4.5
rs619203 CC 20 7.2 26 6.5 0.520
CG 133 47.7 174 43.8
GG 126 45.1 197 49.6
rs1333049 CC 68 24.7 75 18.0 0.052
CG 149 54.2 230 55.2
GG 58 21.1 112 26.9
rs10757278 AA 66 23.5 111 26.6 0.059
AG 142 50.5 229 54.9
GG 73 26.0 77 18.5
a p-Value – x2 test according to Pearson.
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All of the studied single nucleotide polymorphisms did not
show the association with sudden cardiac death in general groups.
By separating the groups of sex and age differences in the genotype
and allelic frequencies of rs1333049, rs10757278 and rs499818
are statistical signiﬁcance. Rs17465637, rs2549513, rs1376251,
rs4804611, rs619203 did not show the association with sudden
cardiac death in our study even in the separation groups by age
and sex.
Rs17465637 has been several times tested for its association
with cardiovascular diseases. The ﬁrst study, performed in the
United Kingdom, succeeded in ﬁnding a correlation between this
polymorphism and IHD.10 Later, the association with IHD was not
conﬁrmed by the PAGE study.11 The association of this polymor-
phism with MI was not also conﬁrmed in Russia.12 However,
studies with United States and Japanese populations detected the
association of rs17465637 with MI development.3,13 Association of
rs17465637 with cardiovascular death, non-fatal myocardial
infarction and non-fatal stroke was not conﬁrmed in COntrolled
ROsuvastatin multiNAtional Trial in Heart Failure (CORONA)
trial.14 In addition, this SNP is likely to be associated with
atherosclerosis; in one study, it showed an association with
atherosclerosis, however, multifactorial analysis demonstrated
that this association was statistically insigniﬁcant.15
The association rs2549513 with MI has been conﬁrmed by the
PAGE study with a US population; however, Russian study has not
demonstrated any statistically signiﬁcant distinctions in the
genotype frequencies between the MI group and control.11,12
The association of rs1376251 with MI was tested in the studies
performed in Germany and Russia.12,16
According to the data on the association of rs4804611 with MI
in Japan, the G allele of associated with an increased risk for MI.17 A
statistically signiﬁcant effect of this SNP on development of IHD in
American Caucasians has been also demonstrated in a PAGE
study.11 The association of this SNP with MI has not beenPlease cite this article in press as: Ivanova AA, et al. Association of th
death, Indian Heart J. (2016), http://dx.doi.org/10.1016/j.ihj.2016.07.conﬁrmed in case–control studies in Germany and Russia.12,16 The
association of GG genotype rs4804611 was showed in recent
meta-analysis involved ﬁve eligible studies, 11,639 subjects
(6299 patients and 5340 healthy controls).18
Association of rs619203 with MI was conﬁrmed in a study
conducted by Zee et al.19 Analysis of a Siberian population has
succeeded in detecting statistically signiﬁcant differences between
the MI group and the control.12 The association with MI has not
been validated in Germany and with IHD, in a case–control study in
Greece.16,18
Polymorphisms rs17465637, rs2549513, rs1376251, rs4804611,
rs619203 studied for association with sudden cardiac death the ﬁrst
in the world. And so we cannot conclude that these polymorphisms
do not play role in development of sudden cardiac death. Absence of
association may be due to the genetic characteristics of our
population or small size of group in our study.
Our results do not contradict the results of worldwide research
to ﬁnd the association of rs1333049 and rs10757278 with
cardiovascular diseases. In Framingham Heart Study a 13-Kb locus
of chromosome 9 (9p21) displayed the association of MI, stroke, and
fatal IHD outcome; this locus contains several SNPs, including
rs1333049 and rs10757278.6 Rs1333049 was in the list of SNPs
associated with MI, IHD based on the results obtained in a genome-
wide study WNCCC, German MI Family study.8 The association with
IHD has been earlier shown for rs1333049 in the studies conducted
in the United States, Portugal, China, Turkey, Iran.2,20–23,27 The C
allele of this SNP is also associated with an earlier onset of angina
pectoris, MI, and early need in cardiovascular therapy, as has been
shown by the study of IHD (Coronary Disease Cohort Study) and MI
(Post-Myocardial Infarction) cohorts.24 Also homozygous carriers
CC genotype of the rs1333049 showed a reduced risk of 1 year
recurrent myocardial infarction, although the C allele had conferred
susceptibility to their ﬁrst acute myocardial infarction in Japan.25
Homozygous CC of the rs1333049 was at a higher risk of suffering
myocardial infarction in Austrian cohort.26 In addition, rs1333049
and rs10757278 associated with atherosclerosis. Rs10757278 ise genetic markers for myocardial infarction with sudden cardiac
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The C allele of rs1333049 polymorphism is associated with an
increased risk for atherosclerotic plaque development as well as
earlier MI onset and severe course.4,5,15 The carriers of CC genotype
displayed an elevated level of triglycerides and cholesterol in the
blood.24 In 2011, polymorphisms rs1333049 and rs10757278 were
for the ﬁrst time tested in a PAGE study for their correlation
according to linkage disequilibrium in two population groups; the
correlation coefﬁcient amounted to 0.85 and higher; correspond-
ingly, only one SNP of this region was involved in the further study.
The results demonstrated that the association with IHD was more
pronounced in the individuals before 55 years old and in women.11
Recent large-scale meta-analysis suggests that rs10757278 (or its
proxy rs1333049) polymorphism is signiﬁcantly associated with MI
again.29 According to the results of our study male carriers of the
genotype GG rs10757278 and CC genotype rs1333049 have an
increased risk of SCD. These results completely match the earlier
study with a Siberian population on the association of SNPs with
MI.16 In addition we showed that rs1333049 and rs10757278 is in
linkage disequilibrium, that completely match the foreign study.
Rs499818 was identiﬁed by genome-wide results of the
Framingham Heart Study as the most likely outcomes associated
with advanced coronary artery disease: MI, stroke, and fatal IHD
outcome.6 Association of this SNP with MI was conﬁrmed by the
Population Architecture using Genomics and Epidemiology (PAGE)
study of multiethnic sample of individuals from four prospective
American studies and a Siberian population.11,12 According to the
latter, the share of genotype AA carriers in the MI group was lower
as compared with the control group (OR = 0.4; 95% CI, 0.2–0.9;
p = 0.03).12 On the group SCD conﬁrm this pattern was not possible,
despite the pathophysiological proximity of MI and SCD. Studies
conﬁrming the results of Framingham Heart Study on association
rs499818 with death from coronary heart disease in the world
have been undertaken. According to our results in the group of
women over 50 years old AG genotype rs499818 is associated with
increased risk of SCD.
5. Study limitations
The limitations of this study included a small sample size. The
results may not translate to patients of other ethnicities without
special veriﬁcation because study included only Russian.
6. Conclusion
The association of polymorphisms rs17465637, rs2549513,
rs1376251, rs499818, rs4804611, rs619203, rs1333049, and
rs10757278 with sudden cardiac death in a Russian population
was studied for the ﬁrst time. Polymorphisms rs1333049 and
rs10757278 are associated with SCD in men and rs499818 in the
women aged over 50 years.
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